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a b s t r a c t
Purpose: To evaluate patterns of lymph flow from primary lesions in patients with cervical
cancer and to determine how useful for radiotherapy planning this information can be.
Materials and methods: SPECT–CT visualization of sentinel (SLN) lymph nodes (LNs) was
performed in 36 primary patients with IB-IIB cervical cancer. The acquisition started
120–240 min after 4 peritumoral injections of 99mTc-radiocolloids (150–300 MBq in 0.4–1 ml).
We determined localization of LN with uptake of radiocolloids, type of lymph flow (mono-,
bi-lateral) and lymph flow patterns (supraureteral paracervical, infraureteral paracervical
and directly to para-aortic LNs).
Results: SLNs were visualized in 31 of 36 women. Bilateral lymph-flow was detected in 22
(71%), monolateral – in the other 9 (29%) cases. The distribution of SLNs was as follows:
external iliac – 64.5%, internal iliac – 54.8%, obturator – 32.2%, common iliac – 35.5% and
pre-sacral 3.2%. Para-aortic LNs were visualized in 5 (16.1%) patients. The supraureteral
paracervical pattern of lymph flow was identified in 22, infraureteral paracervical – in 4 and
their combination – in the other 5 women.
Conclusion: Visualization of an individual pattern of lymph flow from primary cervical cancer
can be considered as a promising tool for optimization of the volume of irradiated regional
LNs.
© 2018 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o. All rights reserved.
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1. Background
Chemoradiotherapy is the primary treatment method of
patients with cervical cancer staged IB2-IVA where the irradi-
ation of pelvic lymph nodes (LNs) is considered as an integral
component of modern radiotherapy programs. Some authors
propose that combination of pelvic irradiation with radio-
therapy to para-aortic LNs can improve treatment efficacy in
patients with IB-IIIB cervical cancer.1,2 However, other studies
have shown that irradiation of para-aortic LNs do not improve
the recurrence-free and overall survival.3,4 Moreover, it almost
doubles the treatment toxicity. Introduction of state-of-the-
art intensity modulated radiation therapy (IMRT) significantly
decreased the volume of the irradiated normal tissues and
reduced the frequency and severity of side effects.5 At the
same time, the implementation of IMRT technique in clini-
cal practice requires precise anatomical localization of target
LNs which has a significant influence on the treatment efficacy
and safety.6
A sentinel lymph node (SLN) concept occurred and was
developed in the late 20th century. According to that con-
cept, lymphatic spread evolves in a sequential order and SLN
is the first node that received lymph-flow from the tumor.
The accumulated clinical experience confirms that the SLN is
indeed the first node to be involved during regional metastatic
spread.7–9 The idea of “lymph flow guided radiotherapy” repre-
sents logical continuation and development of SLN hypothesis
which proposed that regional dissemination occurs in sequen-
tial fashion. The corner stone of this concept is visualization of
individual patterns of lymph flow from the primary tumor and
subsequent irradiation of those lymph nodes that received
lymph fluid from the primary cancer.10,11 Currently, there are
several reports that analyze a possible role of SLNs visualiza-
tion for radiotherapy planning in patients with breast, prostate
and head and neck cancer.12–14
In this study we analyzed our experience of the visualiza-
tion of individual patterns of lymph flow from the cervical
cancer and evaluation topography of SLNs. We also considered
possible utilization of the obtained data for the optimization
of treatment fields that are used for irradiation of regional LNs
in women with cervical cancer.
2. Materials and methods
This prospective single center study was approved by the
Institutional Ethical Committee. The informed consents were
obtained from all patients before SPECT–CT examination. The
study was performed in a group of 36 cervical cancer patients
aged from 45 to 77 (mean 63; 55–71). A clinical and instru-
mental examination was conducted at the N.N. Petrov Cancer
Research Institute from March 2016 to June 2017. All women
had IB-IIB (cT1b-T2bN0M0) cervical cancer with histological
confirmation of the diagnosis. Whole body PET–CT was not
routinely used for staging of cervical cancer and was substi-
tuted by a chest and abdomen CT. In all cases MRI and US
examinations of pelvic and para-aortic LNs did not reveal signs
of metastatic LN involvement.
The visualization of SLNs was performed by hybrid single
photon emission computed tomography/computed tomogra-
phy (SPECT/CT) imaging. The acquisition started 120–240 min
after the peritumoural injection of 0.4–1.0 ml (150–300 MBq) of
99mTc -radiocolloids with the particle diameter of 100–1000 nm
(“Senti-Scint”, “Technephit”). Radiocolloids were injected
superficially under the visual control in 4 points just around
to the primary lesion in equal aliquots at the 12-, 3-, 6- and 9
o’clock positions.
The acquisition was performed by a high resolution hybrid
camera (Symbia T16, Siemens, Germany) using a low-energy
high-resolution collimator. The study was performed with a
patient in a supine position. The study started with a sin-
gle photon emission computed tomography (SPECT) with the
following parameters: 128 × 128 matrix, scan step of 3◦, expo-
sure time of 16 s, and each detector rotation angle of 180◦.
The upper bound of the scanning region was located at the
level of the twelve thoracic vertebrae (Th12), the lower one
was 1–2 cm below the femoral heads. After completion of the
SPECT study (without changing the patient position on the
table), the helical computed tomography (CT) was performed
with the exposure of 80–100 mAs, 120 kV with rotation time of
0.5 s, scan time of 15 s, a pitch of 1 mm, slice thickness of 5 mm
with reconstruction interval of 1.5 mm.
The post-processing fusion of SPECT and CT images was
performed on the Siemens Syngo Workstation: for scinti-
graphic data an iterative reconstruction technique was used
(8 iterations and 16 subsets), with and without the attenua-
tion correction. The total time of a single SPECT–CT study was
16–20 min.
Hybrid images were evaluated by two experts (a radiation
oncologist and a radiologist) with over 10 years’ experience.
They analyzed the number of visualized SLNs and their
anatomical location. All lymph nodes that accumulated radio-
colloids were regarded as SLN. They were assigned to 6 nodal
groups against their anatomic location in relation to blood
vessels. These groups were defined as follows (Fig. 1):
1. Obturator nodes that were localized within a triangle
between external and internal iliac vessels.
2. Internal iliac nodes were next to the internal iliac vessels
and their branches.
3. External iliac nodes corresponded to the nodes around the
external iliac vessels from bifurcation of common iliac ves-
sels to femoral artery.
4. Pre-sacral nodes localized anterior to and in close vicinity
to the sacrum.
5. Common iliac nodes were defined as all LNs that were
within 10 mm around the common iliac vessels from bifur-
cation of the aorta to the division of the common iliac
vessels.
6. Para-aortic LNs determined as LNs adjacent to the aorta or
inferior vena cava from the Th12-L1 to the inferior border
of L4 vertebrae (the level of aorta bifurcation).
In addition, one of 3 main patterns (Fig. 2) of lymph flow
from the uterine cervix was determined in every woman15:
1. Supraureteral paracervical route with lymphatic flow from
cervical lymphatic plexus along the uterine artery to the
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Fig. 1 – Sentinel lymph nodes with uptake of 99mTc-radiocolloids: (a) obturator, (b) external iliac, (c) internal iliac, (d)
presacral, (e) common iliac, (f) para-aortic.
Fig. 2 – Lymph flow patterns and topography of the regional lymph nodes in patients with cervical cancer: 1. obturator, 2.
external iliac, 3. internal iliac, 4. presacral, 5. common iliac, 6. para-aortic, 7. inguinal; solid lines – main routes of lymph
flow from the cervix; dotted lines – possible routes that we were not able to visualize in our patients.
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external iliac and obturator LNs and subsequently running
to the common iliac and para-aortal LNs.
2. Infraureteral paracervical route with lymph flow to the
internal iliac or/and pre-sacral LNs and then draining to
the common iliac and para-aortic LNs.
3. The third pathway is characterized by direct draining from
primary tumor to the para-aortic LNs.
Finally, all patients underwent radical surgical treatment
with subsequent postoperative radiotherapy in patients with
deep stromal involvement, tumor diameter of more than 4 cm
or lymphovascular invasion. According to an institutional
protocol, SLN biopsy precedes a complete bilateral pelvic lym-
phadenectomy without routine para-aortic LN dissection.
Postoperative external beam irradiation of pelvic lymph
nodes was performed without taking into account results of
SPECT–CT examination. Radiation portals were arranged to
cover the common iliac, presacral, internal and external iliac
LNs.6
At the end of the study, we discussed how SPECT–CT
information about distribution of SLNs can be used for indi-
vidual optimization of clinical target volumes for irradiation
of regional LNs in women with cervical cancer.
3. Results
In this cohort of 36 women with cervical cancer (30–77 years
old), SPECT–CT examination successfully visualized sentinel
lymph nodes in 31 (86%) patients. The uptake of radiocolloids
was mentioned in 81 SLNs. The number of detected LNs varied
between 1 and 6; in average 2.6 SLNs per patient. The unilateral
pattern of lymph flow was found in 9 (29%), bilateral – in 22
(71%) observations (Fig. 3).
The histological examination of the excised LNs deter-
mined node invasion by cervical cancer in 4 cases (11.1%). In 3
women metastases were localized only in SLN, in one woman
with lymph flow block and non-visualized SLNs, metastases
were revealed in four pelvic LNs. In other 3 women with non-
visualized SLN the histological examination did not reveal
pelvic metastases. The distribution of pelvic LNs according
to the groups is represented in Fig. 4. The external iliac LNs
accumulated radiocolloids in 20 patients (64.5%), internal iliac
LNs – in 17 (54.8%), obturator LNs – in 10 (32.2%) and pre-
sacral LNs – in one (3.2%) woman. Common iliac LNs were
visualized in 11 (35.5%) cases and in all but 2 observations
were associated with the visualization of SLNs in the obtu-
rator, external and/or internal iliac groups. Para-aortic LNs
were detected in 5 (16.1%) women and in all cases were associ-
ated with tracer uptake in the pelvic LNs. Probably, LNs of the
para-aortic region can be considered as the second echelon
nodes.
In 31 cases, we were able to determine patterns of lymph
flow from cervical cancer: supraureteral paracervical route
was identified in 22, infraureteral paracervical – in 4 and their
combination – in other 5 patients. We did not see any case
of direct lymph flow from primary tumor to the para-aortic
LNs.
4. Discussion
The irradiation of pelvic LNs is an obligatory component of
concurrent chemoradiotherapy program both in patients with
stage IB-IIA and IIB-IV cervical cancer. According to consensus
guidelines, the LNs clinical target volume should include the
entire anatomical pelvic LNs distribution: external, internal
and common iliac LNs, obturator and pre-sacral LNs.6
The evaluation of metastatic LN distribution in patients
with cervical cancer demonstrated that the most frequently
affected nodes were the obturator and/or external iliac LNs
(27–91% cases), less frequently – internal iliac LNs (14–16%
cases), while the pre-sacral LNs were very rarely affected (1–5%
cases).16–18 The sentinel concept postulates that a SLN is the
first node or group of nodes that a cancer cell drains and
invades in during the metastatic process. The visualization of
SLNs can help to determine the individual patterns of lymph
flow from the tumor and to identify LNs with the highest risk of
metastatic involvement. Meta-analysis of 47 prospective stud-
ies (4130 patients) demonstrated that in early stage cervical
cancer patients without metastases in SLNs the estimated risk
of occult metastatic lesions in regional LN is only 0.08%.8 Our
experience illustrated that in most of the evaluated women
with cervical cancer the SLNs were detected in the obturator
(32.2%), external (64.5%), internal (54.8%) and common (35.5%)
iliac groups of the pelvic region. These data correspond to the
“classical” view on topography of regional LNs with the ele-
vated risk of involvement by cervical cancer which must be
covered by standard radiotherapy fields.6 Obtained results are
consistent with the literature data. Diaz et al.,19 indicates that
in most cases SLNs are detected in the external iliac (35%),
internal iliac (30%) and obturator (20%) subgroups. Accord-
ing to Marnitz et al.,20 most SLNs (71%) are located between
external and internal iliac vessels which the authors called
an “interiliac region”. Salvo et al.21 also show that the most
frequent locations can be found in the obturator and internal
iliac LN (41.9%) and external iliac LN (31.6%). At the same time
authors mentioned that SLNs were very rarely (0.6%) located in
the pre-sacral region. In the literature analysis performed by
Marnitz et al.20 the percent of SLNs visualized in the pre-sacral
region varied between 0.8% and 4.6% in the largest series.
Kasuya et al.16 proposed that taking into account low prob-
ability of metastatic invasion of the pre-sacral LNs, the latter
can be excluded from the irradiation volume at least in some
patients with cervical cancer. Such reduction of clinical target
volume can lead to lower toxicity of the radiotherapy program.
In our patients the lymph flow to the pre-sacral nodes was
noticed in 3.2% cases. Probably, in the remaining 30 patients
pre-sacral LNs can be excluded from the irradiation volume.
According to our findings, SLNs were visualized unilaterally
in 29% of our patients. In previously reported studies, the rate
of unilateral location of SLNs varied between 28% and 46%.20,8
In this regard, Altgassen et al.18 mentioned that the pelvic
basin must be regarded as a unit and “if one SLN was detected,
bilateral LN dissection could be omitted”. On the other hand,
Marnitz et al. (2006) proposed a “systematic complete lym-
phadenectomy” on the side where no SLNs were detected. For
safety reasons, we are not proposing unilateral LNs irradiation
in women with unilateral location of SLNs.
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Fig. 3 – Bilateral and unilateral patterns of lymph flow from the cervical cancer: (a) unilateral lymph flow pattern with
99mTc-radiocolloids uptake in the left external iliac, common iliac and para-aortic lymph nodes. (b) Bilateral lymph flow
with 99mTc-radiocolloids uptake in the left and right obturator lymph nodes.
Fig. 4 – Topography of visualized lymph nodes in patients with cervical cancer: obturator – in 10 (32.2%), external iliac – in
20 (64.5%), internal iliac – in 17 (54.8%), presacral – in 1 (3.2%), common iliac – in 11 (35.5%), para-aortic – in 5 (16.1%) cases.
As mentioned earlier, the prophylactic irradiation of the
para-aortic LNs is a subject of long lasting debates. At the
end of the 20th century, RTOG randomized trial demon-
strated that prophylactic irradiation of pelvic and para-aortic
LNs significantly improves the overall survival and decreases
the rate of distant metastases.1 On the other hand, EORTC
trial did not demonstrate any advantage of para-aortic LNs
irradiation but showed a significant increase of toxicity in
patients who had undergone the extended field radiotherapy.4
More recently, Yap et al.3 evaluated the role of prophylactic
para-aortic LNs irradiation in patients with cervical cancer
who had undergone chemoradiotherapy. The authors con-
cluded that “the addition of para-aortic LNs irradiation to
pelvic radiotherapy seems to offer little benefit to patients
with locally advanced cervical cancer”. At the same time
Liang et al.2 compared results of chemoradiotherapy with
pelvic and para-aortic LN irradiation that was prospectively
performed in 31 cervical cancer patients with historical
control group that was represented by 47 women with cer-
vical cancer. Analyses of treatment results demonstrated
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that the extended field radiotherapy covers pelvic and para-
aortic LNs associated with significant improvement in overall,
disease free and distant metastatic free survival: 87% vs.
62%, 82% vs. 54% and 79% vs. 57%, respectively. The acute
myelotoxicity was mentioned in 27.8% of treated patients
and was determined by the authors as the major limita-
tion.
In our point of view, it is reasonable to propose that at least
a small group of women with cervical cancer without instru-
mental signs of LNs involvement can benefit from prophylactic
para-aortic LNs irradiation. At the same time, in many of these
patients radiotherapy to the para-aortic region would cause
additional toxicity only.
It is possible to propose that the lymph flow to the
para-aortic LNs must precede their metastatic involvement.
It means that women with radiocolloids uptake in the
para-aortic LNs can be the best candidates for prophylactic
irradiation of this region. At the same time, non-visualization
of the para-aortic SLNs can be used as an additional argument
against radiotherapy to the para-aortic nodes in patients with
early cervical cancer. Analysis of the literature indicates that
during the SLN procedure para-aortic LNs can be visualized
in 3–10% cases. According to our data radiocolloids uptake
in the para-aortic LNs was determined in 16.1%. This can be
explained by high sensitivity of the SPECT–CT technique and
substantial delay (2–4 h) from tracer injection to the acquisi-
tion start.
The presented data have several limitations. The low num-
ber of the evaluated patients with few cases of LN node
invasion prevents from making a convincing conclusion on
the risk of metastatic invasion of non-visualized pelvic LNs,
particularly nodes that are located cranially from visualized
SLNs. Unfortunately, a histological examination of para-aortic
nodes was not performed even in women with visualized LNs
in the para-aortic region, and we were not able to assess any
correlation between the probability of metastatic involvement
of para-aortic LNs and their visualization with radiocolloids
during the SLN procedure. In addition, as we did not perform
dynamic acquisition, it is possible to propose that at least
some of the visualized para-aortic LNs can be the second ech-
elon nodes. In the same time, according to widely accepted
definition after pericervical/peritumoural injection of radio-
colloids all hot LNs are considered as SLNs.18,20,22 We accept
this concept in our study.
In conclusion, SPECT–CT examinations with radiocolloids
demonstrated a substantial variability in the location of SLNs
in women with cervical cancer. The visualization of individual
patterns of lymph flow from primary tumor can be considered
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